The evaluation of efficacy and safety of new Iranian filgrastim brand drug (PDgrastim*) in treatment of leukemic patients neutropenia

• In: Hospital Pharmacy - Posters
• At: Basel (Switzerland) (2008)
• Type: Poster
• Poster code: HPS-P-080
• By: SOHREVARDI, Seyed mojtaba (Faculty of pharmacy, Kerman, Iran)
• Co-author(s): Kalantari, Behjat (Faculty of medicine, Kerman, Iran)
  Jalali, Seyed pouyan (Faculty of medicine, Kerman, Iran)
  
• Abstract:

  The acute leukemias are clonal hematopoietic malignant disease that arise from the malignant transformation of an early hematopoietic stem cell, leukemia occurs in 8 to 10 in 100,000 people. these patients usually suffer than several weeks of neutropenia due to chemotherapy. We decided to evaluate the efficacy and safety of PDgrastim* (The new

  ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login